These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Prevalence and contributing factors of nonsusceptibility to imipenem or meropenem in extended-spectrum β-lactamase-producing Klebsiella pneumoniae and Escherichia coli. Park YJ, Yu JK, Park KG, Park YG, Lee S, Kim SY, Jeong SH. Diagn Microbiol Infect Dis; 2011 Sep; 71(1):87-9. PubMed ID: 21397426 [Abstract] [Full Text] [Related]
45. CTX-M and SHV-12 beta-lactamases are the most common extended-spectrum enzymes in clinical isolates of Escherichia coli and Klebsiella pneumoniae collected from 3 university hospitals within Korea. Kim J, Lim YM, Rheem I, Lee Y, Lee JC, Seol SY, Lee YC, Cho DT. FEMS Microbiol Lett; 2005 Apr 01; 245(1):93-8. PubMed ID: 15796985 [Abstract] [Full Text] [Related]
46. Occurrence, prevalence and genetic environment of CTX-M beta-lactamases in Enterobacteriaceae from Indian hospitals. Ensor VM, Shahid M, Evans JT, Hawkey PM. J Antimicrob Chemother; 2006 Dec 01; 58(6):1260-3. PubMed ID: 17071956 [Abstract] [Full Text] [Related]
51. Genetic characterisation of CTX-M-15-producing Klebsiella pneumoniae and Escherichia coli strains isolated from stem cell transplant patients in Tunisia. Abbassi MS, Torres C, Achour W, Vinué L, Sáenz Y, Costa D, Bouchami O, Ben Hassen A. Int J Antimicrob Agents; 2008 Oct 01; 32(4):308-14. PubMed ID: 18620848 [Abstract] [Full Text] [Related]
52. Subgrouping of ESBL-producing Escherichia coli from animal and human sources: an approach to quantify the distribution of ESBL types between different reservoirs. Valentin L, Sharp H, Hille K, Seibt U, Fischer J, Pfeifer Y, Michael GB, Nickel S, Schmiedel J, Falgenhauer L, Friese A, Bauerfeind R, Roesler U, Imirzalioglu C, Chakraborty T, Helmuth R, Valenza G, Werner G, Schwarz S, Guerra B, Appel B, Kreienbrock L, Käsbohrer A. Int J Med Microbiol; 2014 Oct 01; 304(7):805-16. PubMed ID: 25213631 [Abstract] [Full Text] [Related]
53. Emergence of OXA-48-producing Klebsiella pneumoniae and the novel carbapenemases OXA-244 and OXA-245 in Spain. Oteo J, Hernández JM, Espasa M, Fleites A, Sáez D, Bautista V, Pérez-Vázquez M, Fernández-García MD, Delgado-Iribarren A, Sánchez-Romero I, García-Picazo L, Miguel MD, Solís S, Aznar E, Trujillo G, Mediavilla C, Fontanals D, Rojo S, Vindel A, Campos J. J Antimicrob Chemother; 2013 Feb 01; 68(2):317-21. PubMed ID: 23034714 [Abstract] [Full Text] [Related]
54. Advantage of the F2:A1:B- IncF Pandemic Plasmid over IncC Plasmids in In Vitro Acquisition and Evolution of blaCTX-M Gene-Bearing Plasmids in Escherichia coli. Mahérault AC, Kemble H, Magnan M, Gachet B, Roche D, Le Nagard H, Tenaillon O, Denamur E, Branger C, Landraud L. Antimicrob Agents Chemother; 2019 Oct 01; 63(10):. PubMed ID: 31332067 [Abstract] [Full Text] [Related]
55. Molecular characterization of a novel blaCTX-M-3-carrying Tn6741 transposon in Morganella morganii isolated from swine. Luo X, Zhai Y, He D, Cui X, Yang Y, Yuan L, Liu J, Hu G. J Med Microbiol; 2020 Aug 01; 69(8):1089-1094. PubMed ID: 32692646 [Abstract] [Full Text] [Related]